Charles Divita III sold $152k of TDOC
CHIEF EXECUTIVE OFFICER at Teladoc Health, Inc.. 27,731 shares at an average of $5.49, traded Mar 11, 2026, filed Mar 12, 2026.
Score components
- +25RoleCEO
- +11Trade size$152k at market
- 0Share of holdings soldSold 7.1% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001347535-26-000004, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 10, 2026 | MOption exercise Common Stock | +39,160 | - | - | 367,022 | Mar 12, 2026 |
| Mar 10, 2026 | MOption exercise Common Stock | +25,493 | - | - | 392,515 | Mar 12, 2026 |
| Mar 11, 2026 | SOpen-market sale Common Stock | -27,731 | $5.49 | $152k | 364,784 | Mar 12, 2026 |
| Mar 10, 2026 | MOption exercise Restricted Stock Unitsderivative | -39,160 | $0.00 | $0 | 195,803 | Mar 12, 2026 |
| Mar 10, 2026 | AGrant or award Performance Stock Unitsderivative | +43,703 | $0.00 | $0 | 43,703 | Mar 12, 2026 |
| Mar 10, 2026 | MOption exercise Performance Stock Unitsderivative | -25,493 | $0.00 | $0 | 18,210 | Mar 12, 2026 |
Related signals
Other insiders at Teladoc Health, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | TDOCsell Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $3,703 655 shares | -4% | |
| 35Weak | Teladoc Health, Inc. | Charles Divita III CHIEF EXECUTIVE OFFICER | $109k 17,805 shares | -4% | |
| 26Weak | Teladoc Health, Inc. | Kelly Bliss President, U.S. Group Health | $46k 7,357 shares | -7% | |
| 15Weak | Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $1,726 274 shares | -2% | |
| 35Weak | Teladoc Health, Inc. | Charles Divita III CHIEF EXECUTIVE OFFICER | $115k 18,327 shares | -4% | |
| 26Weak | Teladoc Health, Inc. | Carlos Nueno President, International | $39k 6,200 shares | -9% | |
| 30Weak | Teladoc Health, Inc. | Fernando M. Rodrigues President of BetterHelp | $98k 15,251 shares | -100% | |
| 22Weak | Teladoc Health, Inc. | Adam C Vandervoort CHIEF LEGAL OFFICER, SECRETARY | $48k 7,573 shares | -6% | |
| 36Weak | Teladoc Health, Inc. | Kelly Bliss President, U.S. Group Health | $136k 26,647 shares | -24% | |
| 20Weak | Teladoc Health, Inc. | Joseph Ronald Catapano Chief Accounting Officer | $6,821 1,333 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.